is semaglutide off patent Semaglutide: Just Another Off-Patent Generic? Or a Different Beast Entirely? On March 20, 2026, the protecting Novo Nordisk's expired in India. Within 24 hours, the market transformed. Leading pharmaceutical giants Novo Nordisk patent expiry opens

On the other hand, individuals recovering from an illness, managing chronic conditions, or addressing significant nutritional deficiencies may benefit from more frequent treatments initially, potentially several times per week, before gradually decreasing sessions as their health improves

If the spot gets sore later, using a cool compress works better

(The drug is not approved for people under 18)

By lowering oxidative stress and helping to regulate inflammatory responses, BR+ NAD therapy may help your brain cells function in a healthier way

Review of Phase II applications submitted in September 2025 was paused during the lapse in SBIR/STTR authorization

The drug regulator has asked the state authorities to ensure that manufacture/import, distribution, retail/wholesale sales, and dispensing occur only through authorised channels and strictly in line with approved indications and labelling, in an advisory dated March 27